Is DH or GDRX more undervalued in 2026?

CirclFi compares Definitive Healthcare Corp. (DH) and GoodRx Holdings, Inc. (GDRX) using 13 institutional-grade valuation models. DH has a Quality of Company score of 7.4/10 while GDRX scores 7.7/10.

Which is a better buy — DH or GDRX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do DH and GDRX valuations compare?

DH at $0.89 and GDRX at $2.97 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

DH vs GDRX Valuation Comparison 2026 — Intrinsic Value Analysis

DH

Health Information Services

Definitive Healthcare Corp.

Quality

7.4

out of 10

Value Trap

SAFE

Price

$0.89

Last close

Models

10/13

Active

GDRX

Health Information Services

GoodRx Holdings, Inc.

Quality

7.7

out of 10

Value Trap

LOW

Price

$2.97

Last close

Models

13/13

Active

Model-by-Model Comparison

Model	Type	DH Fair Value	DH Upside	GDRX Fair Value	GDRX Upside
Bayesian DCF	Intrinsic	—	—	$9.08	+205.8%
Earnings Power Value	Intrinsic	$2.12	+115.0%	$1.54	-48.2%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.67	-24.2%	$1.63	-45.2%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for DH vs GDRX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

DH vs GDRX — Which Stock Is More Undervalued?

GDRX scores higher with a 7.7/10 quality rating vs DH's 7.4/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Definitive Healthcare Corp. (DH) and GoodRx Holdings, Inc. (GDRX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

DH currently trades at $0.89 with a QOC of 7.4/10, while GDRX trades at $2.97 with a QOC of 7.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).